|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Deferred offering costs | ||||||||
| Class A | ||||||||
| Total deferred offering costs | ||||||||
| Current assets | ||||||||
| Cash | ||||||||
| Prepaid expenses | ||||||||
| Total current assets | ||||||||
| Marketable securities held in Trust Account | ||||||||
| Total Assets | ||||||||
| LIABILITIES, TEMPORARY EQUITY AND PERMANENT DEFICIT | ||||||||
| Current liabilities | ||||||||
| Accrued offering costs | ||||||||
| Accrued expenses | ||||||||
| Advance from related party | ||||||||
| Accounts payable and accrued expenses | ||||||||
| Advances from related party | ||||||||
| Promissory note - related party | ||||||||
| Total current liabilities | ||||||||
| Deferred underwriting fee payable | ||||||||
| Warrant liabilities | ||||||||
| Total Liabilities | ||||||||
| Class A ordinary shares subject to possible redemption, 115,000,000 shares issued and outstanding at redemption value at June 30, 2022 and December 31, 2021 | ||||||||
| Class A Common Stock Subject to Redemption | ||||||||
| Total class A ordinary shares subject to possible redemption, 115,000,000 shares issued and outstanding at redemption value at June 30, 2022 and December 31, 2021 | ||||||||
| Permanent Deficit | ||||||||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding | ||||||||
| Ordinary shares, value issued | ||||||||
| Class A | ||||||||
| Class B | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Total Permanent Deficit | ||||||||
| TOTAL LIABILITIES, TEMPORARY EQUITY AND PERMANENT DEFICIT |
Loading...
